Cantabio Pharmaceuticals Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Cantabio Pharmaceuticals is a small biotechnology company based in Sunnyvale, California, focused on preclinical research targeting Parkinson’s disease, Alzheimer's disease, and other neurodegenerative disorders. It aims to translate its experimental findings into therapies and the related intellectual property generated by its research activities. The company pursues an integrated discovery approach that combines a focused therapeutic objective, insights into target biophysics, and drug discovery capabilities to identify and advance small molecule pharmacological chaperones into clinical testing, while also developing therapeutic proteins that can cross the blood-brain barrier to supplement deficient proteins in diseased states. In February 2024 Cantabio announced the development of an engineered cell-penetrant DJ-1 capable of entering cells and distributing widely in vivo. This milestone highlights the company’s focus on innovative approaches within neurodegenerative disease research as it advances its preclinical program.
1-888-653-2347 
support@leadiq.com 
